Avalor Therapeutics (“Avalor”) is funded by US and European investors. Accredited investors and biotech/pharma companies interested in partnering please connect with us below
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.